Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ESTA NASDAQ:IRTC NASDAQ:TNDM NYSE:WRBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeESTAEstablishment Labs$91.04-0.6%$76.37$33.35▼$92.83$2.68B1.06562,270 shs666,515 shsIRTCiRhythm Technologies$125.09-0.7%$115.28$100.85▼$212.00$4.11B1.27612,375 shs539,010 shsTNDMTandem Diabetes Care$15.43+0.1%$16.34$9.98▼$29.65$1.06B1.582.17 million shs1.21 million shsWRBYWarby Parker$28.07-3.9%$25.93$14.96▼$31.00$3.01B1.913.22 million shs2.21 million shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceESTAEstablishment Labs+2.59%+4.74%+23.21%+55.16%+108.61%IRTCiRhythm Technologies-0.36%+6.43%+16.58%+6.24%-11.47%TNDMTandem Diabetes Care+0.65%-2.59%-20.27%-15.65%-9.63%WRBYWarby Parker+0.34%-2.48%+29.04%+38.61%+31.57%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeESTAEstablishment Labs$91.04-0.6%$76.37$33.35▼$92.83$2.68B1.06562,270 shs666,515 shsIRTCiRhythm Technologies$125.09-0.7%$115.28$100.85▼$212.00$4.11B1.27612,375 shs539,010 shsTNDMTandem Diabetes Care$15.43+0.1%$16.34$9.98▼$29.65$1.06B1.582.17 million shs1.21 million shsWRBYWarby Parker$28.07-3.9%$25.93$14.96▼$31.00$3.01B1.913.22 million shs2.21 million shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceESTAEstablishment Labs+2.59%+4.74%+23.21%+55.16%+108.61%IRTCiRhythm Technologies-0.36%+6.43%+16.58%+6.24%-11.47%TNDMTandem Diabetes Care+0.65%-2.59%-20.27%-15.65%-9.63%WRBYWarby Parker+0.34%-2.48%+29.04%+38.61%+31.57%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceESTAEstablishment Labs 2.67Moderate Buy$87.14-4.28% DownsideIRTCiRhythm Technologies 2.94Moderate Buy$187.3849.80% UpsideTNDMTandem Diabetes Care 2.45Hold$29.1388.76% UpsideWRBYWarby Parker 2.67Moderate Buy$29.826.22% UpsideCurrent Analyst Ratings BreakdownLatest TNDM, IRTC, WRBY, and ESTA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/29/2026WRBYWarby Parker Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$33.006/24/2026ESTAEstablishment Labs Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)6/23/2026TNDMTandem Diabetes Care Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy ➝ Hold$15.506/22/2026IRTCiRhythm Technologies BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$185.006/18/2026IRTCiRhythm Technologies Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/11/2026TNDMTandem Diabetes Care Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/10/2026IRTCiRhythm Technologies BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$185.006/10/2026TNDMTandem Diabetes Care Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold6/8/2026ESTAEstablishment Labs TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy6/2/2026IRTCiRhythm Technologies Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/1/2026IRTCiRhythm Technologies Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$180.00 ➝ $152.00(Data available from 7/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookESTAEstablishment Labs$211.08M12.69N/AN/A$0.81 per share112.40IRTCiRhythm Technologies$747.14M5.50N/AN/A$4.74 per share26.39TNDMTandem Diabetes Care$1.01B1.04N/AN/A$2.29 per share6.74WRBYWarby Parker$871.91M3.45$0.60 per share46.51$3.48 per share8.07Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateESTAEstablishment Labs-$51.06M-$1.49N/A650.29N/A-19.05%-218.77%-12.31%8/6/2026 (Estimated)IRTCiRhythm Technologies-$44.55M-$0.86N/A95.49N/A-3.53%-10.26%-1.39%7/30/2026 (Estimated)TNDMTandem Diabetes Care-$204.71M-$1.40N/A257.17N/A-9.20%-53.88%-7.88%8/6/2026 (Confirmed)WRBYWarby Parker$1.64M$0.021,404.3570.185.850.15%2.30%1.18%8/6/2026 (Estimated)Latest TNDM, IRTC, WRBY, and ESTA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2026Q2 2026IRTCiRhythm Technologies-$0.01N/AN/AN/A$219.29 millionN/A5/7/2026Q1 2026ESTAEstablishment Labs-$0.3550-$0.45-$0.0951-$0.45$57.40 million$59.88 million5/7/2026Q1 2026TNDMTandem Diabetes Care-$0.46-$0.30+$0.16-$0.30$240.41 million$247.22 million5/7/2026Q1 2026WRBYWarby Parker$0.11$0.03-$0.08$0.03$239.44 million$242.45 million4/30/2026Q1 2026IRTCiRhythm Technologies-$0.56-$0.35+$0.21-$0.43$194.11 million$199.39 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthESTAEstablishment LabsN/AN/AN/AN/AN/AIRTCiRhythm TechnologiesN/AN/AN/AN/AN/ATNDMTandem Diabetes CareN/AN/AN/AN/AN/AWRBYWarby ParkerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioESTAEstablishment Labs16.822.961.91IRTCiRhythm Technologies4.035.174.98TNDMTandem Diabetes Care4.543.583.07WRBYWarby ParkerN/A2.332.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipESTAEstablishment Labs72.91%IRTCiRhythm TechnologiesN/ATNDMTandem Diabetes CareN/AWRBYWarby Parker93.24%Insider OwnershipCompanyInsider OwnershipESTAEstablishment Labs9.99%IRTCiRhythm Technologies0.98%TNDMTandem Diabetes Care2.10%WRBYWarby Parker16.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableESTAEstablishment Labs1,00429.43 million26.49 millionOptionableIRTCiRhythm Technologies2,40032.86 million32.54 millionOptionableTNDMTandem Diabetes Care2,50068.53 million67.09 millionOptionableWRBYWarby Parker4,036107.09 million89.10 millionOptionableTNDM, IRTC, WRBY, and ESTA HeadlinesRecent News About These CompaniesSimplify Asset Management Inc. Sells 109,512 Shares of Warby Parker Inc. $WRBYJuly 4 at 5:51 AM | marketbeat.comNeil Harris Blumenthal Sells 217,667 Shares of Warby Parker (NYSE:WRBY) StockJuly 4 at 4:08 AM | americanbankingnews.comWarby Parker (NYSE:WRBY) CEO Sells 217,667 SharesJuly 3, 2026 | insidertrades.comInsider Selling: Warby Parker (NYSE:WRBY) CEO Sells 217,667 SharesJuly 2, 2026 | marketbeat.comWarby Parker (NYSE:WRBY) CEO Sells $1,090,452.00 in StockJuly 2, 2026 | insidertrades.comNeil Harris Blumenthal Sells 36,300 Shares of Warby Parker (NYSE:WRBY) StockJuly 1, 2026 | marketbeat.comSG Americas Securities LLC Invests $2.71 Million in Warby Parker Inc. $WRBYJuly 1, 2026 | marketbeat.comWarby Parker disrupts eyewear industry with full-service eyewear retailer — BofAJune 29, 2026 | seekingalpha.comWarby Parker Has 'Plenty More Than Meets The Eye', Analyst SaysJune 29, 2026 | benzinga.comWarby Parker (NYSE:WRBY) Coverage Initiated by Analysts at Bank of AmericaJune 29, 2026 | marketbeat.comMaridea Wealth Management LLC Raises Holdings in Warby Parker Inc. $WRBYJune 27, 2026 | marketbeat.comWarby Parker (NYSE:WRBY) versus Bolt Projects (NASDAQ:BSLK) Critical SurveyJune 27, 2026 | americanbankingnews.comWhat Does the Sale of Warby Parker Shares Worth $1.9 Million by the Co-CEO Mean for Investors?June 25, 2026 | fool.comVaughan Nelson Investment Management L.P. Purchases 722,627 Shares of Warby Parker Inc. $WRBYJune 22, 2026 | marketbeat.comWarby Parker Inc. (NYSE:WRBY) Given Average Rating of "Moderate Buy" by AnalystsJune 21, 2026 | marketbeat.comWarby Parker (NYSE:WRBY) Director Sells 5,000 SharesJune 19, 2026 | insidertrades.comWarby Parker (WRBY) Unveils First Line of Intelligent Eyewear Powered by Gemini and Android XRJune 19, 2026 | uk.finance.yahoo.comClough Capital Partners L P Makes New $1.57 Million Investment in Warby Parker Inc. $WRBYJune 18, 2026 | marketbeat.com393,085 Shares in Warby Parker Inc. $WRBY Acquired by Atreides Management LPJune 18, 2026 | marketbeat.comIs Warby Parker (WRBY) One of the Best Up and Coming Stocks to Buy for the Next 3 Years?June 17, 2026 | insidermonkey.comSenator Investment Group LP Takes $8.22 Million Position in Warby Parker Inc. $WRBYJune 16, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesMission Control: Floating In SpaceX's Record-Breaking OrbitBy Jeffrey Neal Johnson | June 15, 2026SpaceX Rings the Bell and Shatters Every RecordBy Jeffrey Neal Johnson | June 12, 2026Gravity Check: Houston, SpaceX Has a Valuation ProblemBy Jeffrey Neal Johnson | June 16, 2026These 5 Companies Just Made a Massive Bet on ThemselvesBy Thomas Hughes | June 15, 2026Qualcomm Goes All-In: The $10B Bet to Crush NVIDIABy Jeffrey Neal Johnson | June 18, 2026TNDM, IRTC, WRBY, and ESTA Company DescriptionsEstablishment Labs NASDAQ:ESTA$91.04 -0.52 (-0.57%) Closing price 04:00 PM EasternExtended Trading$91.08 +0.04 (+0.05%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.iRhythm Technologies NASDAQ:IRTC$125.09 -0.94 (-0.75%) Closing price 04:00 PM EasternExtended Trading$125.06 -0.03 (-0.02%) As of 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Tandem Diabetes Care NASDAQ:TNDM$15.43 +0.01 (+0.06%) Closing price 04:00 PM EasternExtended Trading$15.40 -0.03 (-0.16%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.Warby Parker NYSE:WRBY$28.07 -1.15 (-3.93%) Closing price 03:59 PM EasternExtended Trading$27.64 -0.44 (-1.56%) As of 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity Palantir's CEO Just Called Out OpenAI and Anthropic Silicon Starvation: Amazon Feasts on Legacy GPUs GE Vernova’s Power Surge Turns the Grid Into an AI Trade 3 Quiet AI Revenue Accelerators With Sales Growth Outpacing Peers Abivax: Wall Street Catches Up to the Data AI Insider Activity: Are Sales Across 3 Key Stocks Noteworthy or Just Noise? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
